Clinical Trials Logo

Menorrhagia clinical trials

View clinical trials related to Menorrhagia.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03027973 Withdrawn - Clinical trials for Heavy Menstrual Bleeding

Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding

Start date: January 2020
Phase: Phase 1
Study type: Interventional

This study compares two treatments for the management of heavy menstrual bleeding, ulipristal acetate (UPA) and tranexamic acid (TEA), on health-related quality of life. Half of the participants will receive UPA and a placebo, and the other half will receive TEA and a placebo.

NCT ID: NCT01651468 Withdrawn - Menorrhagia Clinical Trials

The Effect of the Nutraceutical "Hemofix" on the Coagulation System

Start date: September 2016
Phase: N/A
Study type: Interventional

Hemofix is a herbal formula based on traditional Jewish and far eastern medicine created to assist in wound healing and bleeding arrest. It contains herbs such as Red Clover, Liquorice, Raspberry, Ginger and more. The present study will evaluate the formula on the coagulation system.

NCT ID: NCT00953641 Withdrawn - Menorrhagia Clinical Trials

Vaginal Misoprostol for Cervical Ripening Prior to Endometrial Biopsy

Start date: September 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether using Misoprostol vaginally before an office endometrial biopsy is performed, will make it easier, more successful and less painful to do the procedure. The investigators' hypothesis is that vaginal Misoprostol 12 hours prior to endometrial biopsy will increase the ease of performing office endometrial biopsy by reducing the need to use a tenaculum or a cervical dilator to achieve passage of a biopsy pipelle.

NCT ID: NCT00768742 Withdrawn - Uterine Fibroids Clinical Trials

Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study

FAST
Start date: September 2008
Phase: N/A
Study type: Interventional

The primary objective of this study is to test the hypothesis that a minimum 75% volume radiofrequency ablation of fibroids associated with menorrhagia results in reduction of menstrual bleeding.